Intermittent Pneumatic Compression (IPC) Devices Global Market Report 2024

The intermittent pneumatic compression (ipc) devices market size has grown rapidly in recent years. It will grow from $1.31 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth observed in the historic period can be attributed to factors such as improved understanding of diseases, increased awareness and diagnosis, changes in healthcare policies, collaborations in clinical trials, and supportive patient advocacy, along with physician education programs.

The intermittent pneumatic compression (ipc) devices market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to factors such as the expanding patient pool, a heightened focus on improving patient quality of life, the growth of research collaborations, global health initiatives, and efforts to increase healthcare access. Major trends expected in the forecast period include the emergence of targeted therapies, the development of both oral and injectable medications, the investigation of immune modulation strategies, the introduction of disease-modifying agents, and an increased focus on personalized medicine approaches.

The growth of the intermittent pneumatic compression (IPC) devices market is anticipated to be driven by the rising number of patients with spinal cord injuries. Spinal cord injuries, which lead to varying degrees of paralysis and sensory impairment below the injury level, are being addressed with IPC devices in order to prevent deep vein thrombosis (DVT) through the promotion of blood circulation via sequential compression of the lower limbs. For example, in 2023, the National Spinal Cord Injury Statistical Center, a US-based government organization, reported approximately 18,000 new cases of spinal cord injuries annually in the United States, with an incidence rate of around 54 cases per 1 million people. This surge in spinal cord injury cases is a key factor propelling the growth of the intermittent pneumatic compression (IPC) devices market.

The increasing number of accidents is expected to contribute to the growth of the IPC devices market. Accidents, defined as unforeseen events causing harm or damage due to unintended circumstances, often result in fractures and soft-tissue injuries. IPC is utilized in the treatment of such injuries arising from accidents. For instance, in October 2023, the European Commission, a government agency in Europe, reported a 4% increase in EU road fatalities, reaching a total of 20,640 deaths compared to the previous year. This upward trend in accident-related fatalities is a significant driver for the growth of the intermittent pneumatic compression (IPC) devices market.

The growth of the intermittent pneumatic compression (IPC) devices market is anticipated to be hindered by the discomfort associated with wearing the device for extended periods. IPC devices may lead to issues such as warmth, sweating, and general discomfort beneath the cuff, potentially limiting patient adherence to the treatment. An article published by the National Library of Medicine in July 2021 reported mild adverse events in a study involving 20 healthy volunteers using IPC, including dizziness, headache, foot discomfort, and palpitations. These inconveniences, such as dizziness and palpitations, were attributed to the intervention, indicating that the prolonged use of IPC devices is impeding market growth.

Major players in the IPC devices market are increasingly focusing on the development of innovative devices, including wearables, to gain a competitive advantage. Wearable IPC devices, such as those designed to be worn on the arm, aim to enhance circulation and prevent deep vein thrombosis during extended periods of immobility. For instance, in March 2022, Fist Assist Devices LLC launched the world's first wearable intermittent pneumatic compression device, Fist Assist Model FA-1. This patent-protected device automates the intermittent pressure application to the arm, promoting vein dilation and aiding in arteriovenous fistula (AVF) for presurgical purposes. The device's automated nature simplifies usage, reducing the risk of user error and contributing to improved blood flow and vein dilation.

In March 2021, Direct Healthcare Group Ltd., a UK-based developer and manufacturer of pressure care products, acquired Talley Group Ltd. This strategic acquisition is expected to enhance Direct Healthcare Group's product range for patients with reduced mobility by incorporating Talley Group's intermittent pneumatic compression systems for deep vein thrombosis prophylaxis into its solution offerings.

Major companies operating in the intermittent pneumatic compression (ipc) devices market report are Cardinal Health Inc., 3M Company, Medtronic PLC, Stryker Corporation, Tyco International PLC, Medline Industries LP, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Getinge AB, Enovis Corporation, Arjo AB, Tactile Systems Technology Inc., ThermoTek Inc., Encompass Group LLC, Hyperice Inc., Breg Inc., Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc.

North America was the largest region in the intermittent pneumatic compression (IPC) devices market in 2023. The regions covered in the intermittent pneumatic compression (ipc) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the Intermittent Pneumatic Compression (IPC) Devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intermittent pneumatic compression (IPC) devices are inflatable sleeves designed to prevent blood clots by applying external pressure to the legs through compressed air and a pump. These devices consist of cuffs that periodically inflate and deflate, facilitating blood flow by compressing and releasing the affected area. IPC is commonly used to enhance limb circulation, prevent deep vein thrombosis (DVT), and manage conditions such as lymphedema.

The main types of intermittent pneumatic compression (IPC) devices are designed for addressing issues related to deep vein thrombosis (DVT) and pulmonary embolism (PE). Deep vein thrombosis (DVT) is a medical condition characterized by the development of blood clots within deep veins, most commonly found in the legs. These devices are available through various distribution channels, including clinics, pharmacies, online channels, and other offline channels, and cater to different applications, including both home use and hospital use.

The intermittent pneumatic compression (IPC) devices market research report is one of a series of new reports that provides intermittent pneumatic compression (IPC) devices market statistics, including intermittent pneumatic compression (IPC) devices industry global market size, regional shares, competitors with an intermittent pneumatic compression (IPC) devices market share, detailed intermittent pneumatic compression (IPC) devices market segments, market trends and opportunities, and any further data you may need to thrive in the intermittent pneumatic compression (IPC) devices industry. This intermittent pneumatic compression (IPC) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intermittent pneumatic compression (IPC) devices market consists of sales of sequential compression devices, gradient compression devices, lymphedema pumps, custom-fit intermittent pneumatic compression (IPC) devices, air compression sleeves, and boots. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.